Hemostemix (HEM) News Today C$0.28 +0.01 (+3.77%) As of 03:59 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartHeadlinesInsider Trades All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Hemostemix Presents at Puerto Rico Investor Summits: Showcasing Global Scale-Up Strategy and Economic ImpactJanuary 20 at 1:10 PM | finance.yahoo.comHemostemix (CVE:HEM) Shares Up 27.9% - Here's WhyJanuary 19 at 4:19 AM | americanbankingnews.comHemostemix (CVE:HEM) Shares Up 27.9% - Time to Buy?January 19 at 3:37 AM | americanbankingnews.comHemostemix (CVE:HEM) Trading Up 27.9% - Still a Buy?January 19 at 2:11 AM | americanbankingnews.comHemostemix Settlement via Depository Trust Company Plus OTCQB UpdateJanuary 14, 2025 | finance.yahoo.comHemostemix (CVE:HEM) Stock Price Up 37.9% - Should You Buy?January 12, 2025 | americanbankingnews.comHemostemix (CVE:HEM) Shares Up 37.9% - Should You Buy?January 12, 2025 | americanbankingnews.comHemostemix (CVE:HEM) Stock Price Up 37.9% - Here's WhyJanuary 12, 2025 | americanbankingnews.comHemostemix (CVE:HEM) Shares Up 37.9% - Here's WhyJanuary 12, 2025 | americanbankingnews.comHemostemix (CVE:HEM) Trading Up 37.9% - Here's WhyJanuary 12, 2025 | americanbankingnews.comHemostemix stock takes off after amended manufacturing dealJanuary 9, 2025 | msn.comHemostemix Inc.: Hemostemix and CytoImmune Amend Manufacturing Agreement to Accelerate Global Scale-UpJanuary 9, 2025 | finanznachrichten.deHemostemix and CytoImmune Amend Manufacturing Agreement to Accelerate Global Scale-UpJanuary 9, 2025 | finance.yahoo.comHemostemix Announces the Incorporation of Hemostemix PR Inc: 50% Reimbursement of R&D Expenses in CashJanuary 6, 2025 | stockhouse.comHemostemix is Up-Listing in the USA to Generate LiquidityJanuary 3, 2025 | finance.yahoo.comHemostemix's Social Media Awareness of "Your Fountain of Youth"(TM) Regenerative Medicine Treatments Is Gaining TractionJanuary 2, 2025 | finance.yahoo.comHemostemix Announces $2,725,982 Update to Second ClosingDecember 4, 2024 | theglobeandmail.comHemostemix Announces ACP-01 Treatment-Purchase Available with Social Media Campaign UnderwayNovember 26, 2024 | finance.yahoo.comHemostemix Announces the First Tranche Closing of $1.8M of Its Recently Announced Private PlacementOctober 31, 2024 | finance.yahoo.comTUGAF TUGA Innovations, Inc.October 26, 2024 | seekingalpha.comHemostemix's Private PlacementOctober 11, 2024 | finance.yahoo.comHemostemix Inc. (CVE:HEM) Director Sells C$21,612.50 in StockOctober 9, 2024 | insidertrades.comCanadian Investment Regulatory Organization Trade Resumption - HEMAugust 2, 2024 | ca.finance.yahoo.comHemostemix Closes its Funded Manufacturing Services Agreement with CytoImmune, Restarting Production of ACP-01August 2, 2024 | finance.yahoo.comCanadian Investment Regulatory Organization Trading Halt - HEMAugust 1, 2024 | finance.yahoo.comClosing Bell: Hemostemix Inc flat on Monday (HEM)July 24, 2024 | theglobeandmail.comGlobal Angioplasty Balloons and Stents Market to Exhibit Substantial Growth at a CAGR of ~4% by 2030 | DelveInsightMay 2, 2024 | finance.yahoo.comHemostemix Inc.: Hemostemix Announces Engagement of Oak Hill Asset Management Inc.March 7, 2024 | finanznachrichten.deHemostemix Announces Engagement of Oak Hill Asset Management Inc.March 7, 2024 | finance.yahoo.comHemostemix: Top 10 Undervalued Healthcare Sector Stocks on TSX-V (HEM)February 20, 2024 | theglobeandmail.comHemostemix: Top 10 Undervalued Biotechnology Industry Stocks (HEM)February 19, 2024 | theglobeandmail.comHemostemix Announces Updated Phase II Randomized Clinical Trial Results Published by the Journal of Biomedical Research and Environmental SciencesFebruary 6, 2024 | finance.yahoo.comHemostemix Inc HMTXFJanuary 19, 2024 | morningstar.comHemostemix Inc.: Hemostemix's 4th Heart Study Published in Stem Cell Research & Therapy Confirms Breakthrough Treatment for Heart DiseaseOctober 30, 2023 | finanznachrichten.deHemostemix's 4th Heart Study Published in Stem Cell Research & Therapy Confirms Breakthrough Treatment for Heart DiseaseOctober 30, 2023 | finance.yahoo.comClosing Bell: Hemostemix Inc down on Thursday (HEM)October 20, 2023 | theglobeandmail.comHemostemix Announces the Incorporation of Hemostemix Quebec Inc. and $6 Million in Grant ApplicationsAugust 29, 2023 | finance.yahoo.comClosing Bell: Hemostemix Inc up on Friday (HEM)August 8, 2023 | theglobeandmail.comHemostemix Inc.: Hemostemix Closes $403,539 of the Unit Private PlacementJune 28, 2023 | finanznachrichten.deClosing Bell: Hemostemix Inc up on Tuesday (HEM)June 28, 2023 | theglobeandmail.comHemostemix Closes $403,539 of the Unit Private PlacementJune 28, 2023 | finance.yahoo.comClosing Bell: Hemostemix Inc down on Monday (HEM)June 27, 2023 | theglobeandmail.comClosing Bell: Hemostemix Inc flat on Wednesday (HEM)June 24, 2023 | theglobeandmail.comHemostemix's Private Placement Use of ProceedsJune 22, 2023 | marketwatch.comClosing Bell: Hemostemix Inc down on Friday (HEM)June 17, 2023 | theglobeandmail.comHemostemix to raise $1.2M through private placement of unitsJune 2, 2023 | msn.comClosing Bell: Hemostemix Inc flat on Tuesday (HEM)May 3, 2023 | theglobeandmail.comHemostemix (PreCerv Inc.) Retains Chris McNorgan PhD to License NCP-01 to Neural Electrode Brain Implant CompanyMay 2, 2023 | finance.yahoo.comClosing Bell: Hemostemix Inc flat on Friday (HEM)April 29, 2023 | theglobeandmail.comClosing Bell: Hemostemix Inc flat on Thursday (HEM)April 21, 2023 | theglobeandmail.com Get Hemostemix News Delivered to You Automatically Sign up to receive the latest news and ratings for HEM and its competitors with MarketBeat's FREE daily newsletter. Email Address HEM Media Mentions By Week HEM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HEM News Sentiment▼0.490.60▲Average Medical News Sentiment HEM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HEM Articles This Week▼50▲HEM Articles Average Week Get Hemostemix News Delivered to You Automatically Sign up to receive the latest news and ratings for HEM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Sernova News Microbix Biosystems News Aeterna Zentaris News Resverlogix News Sirona Biochem News Kane Biotech News Innovotech News Aptose Biosciences News Quest PharmaTech News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (CVE:HEM) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredThis coin could surge during Trump’s first week in office.Juan has never had a losing trade on Bitcoin. And he booked gains of 312% on Chainlink … Now, he says one v...Weiss Ratings | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hemostemix Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hemostemix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
